Clinical Trial Update: Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema [Phase 2, Phase 3]

View source ↗

Summary

Complete Phase 2 and Phase 3 trial updates for recombinant human C1 esterase inhibitor in treating acute attacks of hereditary angioedema, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angioedema
• Hereditary Angioedema

Drugs mentioned

• Recombinant human C1 esterase inhibitor (C1 esterase inhibitor (recombinant))

Snippet

Sponsor: Pharming Technologies B.V. | Conditions: Hereditary Angioedema, Angioneurotic Edema | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-08-31